%0 Journal Article
%B ERJ Open Res
%D 2023
%G eng
%M 37101737
%R 10.1183/23120541.00571-2022
%T Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
%V 9
%2 PMC10123517 Maslova, T.N. Tran and R.J.P. van der Valk are employees of AstraZeneca and hold AstraZeneca shares. R.J.P. van der Valk holds shares in GlaxoSmithKline. G. Roberts and I. Sinha received consultancy from AstraZeneca to their institutions for this work. J.K. Quint reports grants from AUK-BLF and The Health Foundation; grants and personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Bayer; and grants from Chiesi, outside the submitted work. J.K. Quint's research group received funding from AstraZeneca for this work.
%7 2023/04/27
%@ 2312-0541 (Print)
2312-0541